Hexokinase II is a key enzyme in glucose metabolism and repression in Saccharomyces cerevisiae. Deletion of the HXK2 gene, which encodes hexokinase II, significantly alters the physiology of S. cerevisiae. The hxk2-null mutant strain exhibits oxidative growth at high glucose concentrations during early exponential batch cultures, leading to delayed ethanol production, a modified diauxic shift, and increased biomass yield. Intracellular changes in the hxk2 mutant include higher mitochondrial H+-ATPase activity, lower pyruvate decarboxylase activity, and an accumulation of pyruvate. Notably, redirection of carbon flux towards biomass production occurs due to reduced glucose repression in the hxk2 mutant.
Glycolysis is central to glucose metabolism in S. cerevisiae, with glucose phosphorylation being the initial step. The yeast possesses three isozymes that phosphorylate glucose: glucokinase, hexokinase I, and hexokinase II. These isozymes differ in glucose affinity and specificity for other sugars. Transcriptional regulation of these hexose-phosphorylating enzymes varies based on carbon source and availability. Glucose repression, a mechanism adapting yeast cells for glucose fermentation, involves the transcriptional repression of various genes. Glucose repression in S. cerevisiae leads to diauxic growth on glucose.
Glucose repression mechanisms in yeast are complex, with hexokinase II playing a central role. Absence of hexokinase II derepresses high-affinity glucose transport and prevents repression of various enzymes by glucose. Hexokinase II’s sugar-phosphorylating activity and regulatory functions are linked to glucose repression. Deletion of HXK2 leads to significant physiological changes, driving oxidative growth at high glucose levels and altering metabolite concentrations. This redirection of metabolic flux can enhance biomass production in S. cerevisiae.
Experiments involving the HXK2 gene deletion in S. cerevisiae reveal a Crabtree-negative phenotype, characterized by oxidative growth on glucose with delayed ethanol production. The hxk2 mutant strain shows reduced glucose consumption and absence of fermentative by-products during early exponential growth. Metabolite patterns shift towards biomass production, and key intracellular metabolite concentrations fluctuate in the hxk2 mutant compared to the wild type. Furthermore, changes in enzyme activities like hexose phosphorylation and pyruvate decarboxylase activity are observed in the hxk2 mutant.
Physiological characterization of S. cerevisiae cells lacking hexokinase II sheds light on the impact of this deletion on aerobic batch growth. The hxk2 mutant strain displays altered growth characteristics, intracellular metabolite profiles, and enzyme activities, emphasizing the role of hexokinase II in glucose metabolism and repression. These findings suggest that regulatory pathways rather than enzyme overexpression can effectively modulate yeast physiology and steer glucose metabolism towards desired pathways like biomass production or heterologous protein expression.
Key Takeaways:
1. Deletion of the HXK2 gene in S. cerevisiae leads to significant physiological changes, including oxidative growth at high glucose concentrations and altered metabolite concentrations.
2. Absence of hexokinase II results in a Crabtree-negative phenotype, with delayed ethanol production and enhanced biomass yields in yeast cells.
3. Hexokinase II plays a central role in glucose metabolism and repression mechanisms in S. cerevisiae, influencing metabolic flux redirection and intracellular processes.
4. Physiological characterization of hxk2 mutant S. cerevisiae cells provides insights into the regulatory and metabolic consequences of hexokinase II deletion, highlighting new avenues for controlling yeast physiology.
Tags: fed batch, mass spectrometry, yeast, chromatography, centrifugation, regulatory, bioreactor, biotech
Read more on pmc.ncbi.nlm.nih.gov